Parametric Portfolio Associates’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$26K Sell
36,219
-23,045
-39% -$16.5K ﹤0.01% 3655
2021
Q4
$134K Sell
59,264
-30,193
-34% -$68.3K ﹤0.01% 3507
2021
Q3
$258K Sell
89,457
-37,012
-29% -$107K ﹤0.01% 3356
2021
Q2
$479K Sell
126,469
-68,028
-35% -$258K ﹤0.01% 3099
2021
Q1
$658K Sell
194,497
-64,643
-25% -$219K ﹤0.01% 3358
2020
Q4
$726K Buy
259,140
+199,283
+333% +$558K ﹤0.01% 3201
2020
Q3
$150K Sell
59,857
-124,180
-67% -$311K ﹤0.01% 3727
2020
Q2
$2.5M Buy
184,037
+83,340
+83% +$1.13M ﹤0.01% 2364
2020
Q1
$763K Buy
100,697
+32,414
+47% +$246K ﹤0.01% 2950
2019
Q4
$432K Sell
68,283
-145,437
-68% -$920K ﹤0.01% 3423
2019
Q3
$838K Buy
213,720
+14,204
+7% +$55.7K ﹤0.01% 3112
2019
Q2
$966K Buy
199,516
+64,835
+48% +$314K ﹤0.01% 3065
2019
Q1
$1.1M Sell
134,681
-114,788
-46% -$940K ﹤0.01% 2980
2018
Q4
$1.38M Buy
249,469
+227,364
+1,029% +$1.26M ﹤0.01% 2812
2018
Q3
$195K Sell
22,105
-885
-4% -$7.81K ﹤0.01% 3768
2018
Q2
$229K Buy
22,990
+5,626
+32% +$56K ﹤0.01% 3654
2018
Q1
$165K Sell
17,364
-78,100
-82% -$742K ﹤0.01% 3797
2017
Q4
$1.42M Sell
95,464
-9,734
-9% -$145K ﹤0.01% 2822
2017
Q3
$2.07M Buy
105,198
+31,074
+42% +$611K ﹤0.01% 2564
2017
Q2
$1.07M Buy
+74,124
New +$1.07M ﹤0.01% 2950
2016
Q4
Sell
-10,555
Closed -$96K 3767
2016
Q3
$96K Buy
+10,555
New +$96K ﹤0.01% 3685
2016
Q1
Sell
-23,807
Closed -$308K 3966
2015
Q4
$308K Buy
23,807
+12,731
+115% +$165K ﹤0.01% 3549
2015
Q3
$107K Sell
11,076
-666
-6% -$6.43K ﹤0.01% 3181
2015
Q2
$121K Buy
+11,742
New +$121K ﹤0.01% 3850